医药生物行业周报:政策推动中药工业提质升级 中长期利好行业集中度提升

光大证券
Feb 09

行情回顾:上周A 股医药生物指数上涨0.14%,跑赢沪深300 指数1.47pp,跑赢创业板综指2.06pp,在31 个子行业中排名第15。港股恒生医疗健康指数上周收跌1.41%,跑赢恒生国企指数1.65pp。研发进展:上周,恒瑞医药的HRS-9531 递交NDA;和誉生物的ABSK043 临床申请新进承办。上周,先为达的埃诺格鲁肽正在进行三期临床;先声药业的SIM0278 正在进行二期临床;英硒...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10